Rijksinstituut voor Volksgezondheid en Milieu Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome | RIVM Jaar: 2022 Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome | RIVM Bron: rivm.nl Download dossier (ZIP) · JSON